About Corerx Pharma India Private Limited
Data last updated:
Corerx Pharma India Private Limited is a foreign private limited company based in Bangalore, Karnataka, India, a subsidiary of Corerx, Inc, Usa. It operates in the business support services segment of the business services sector. It was incorporated on 13 May 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24304KA2021FTC147384. Its GSTIN is 27AAJCC4795N1ZU (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayesh Patel and Aniket Padmakar Manathkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 87/54 6th Sector Hsr Layout, Bangalore, Karnataka, India – 560102.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.94 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹22.65 Lakh (net margin 4.6%) and EBITDA of ₹42.5 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 61% over three years.
The company has about 18 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: CoreRx.
For more details, the company can be reached via its website corerxpharma.com.
Company details
Contact details
Corerx Pharma India Private Limited's registered office is in Bangalore, Karnataka. Its website is corerxpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address87/54 6th Sector Hsr Layout, Bangalore, Karnataka, India – 560102
- IndustryBusiness Services, Business Support Services
To see the full contact details of Corerx Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Corerx Pharma India operates one associated brand: CoreRx. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| CDMO with a focus on early phase drug product development | corerxpharma.com |
Business activity
The main business activity of Corerx Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Corerx Pharma India Private Limited, buy the company report.
Financials of Corerx Pharma India Private Limited
FY 2025 filings availableCorerx Pharma India Private Limited reported revenue of ₹4.94 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 61% over three years, including 11% growth in the latest year. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹42.5 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹22.65 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 8.6% | |||
| Net Profit Margin | 4.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Corerx Pharma India Private Limited, buy the company report.
Board of directors of Corerx Pharma India Private Limited
Corerx Pharma India has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayesh Patel Also directs: Jwi Ventures LLP, Gbas Technologies Private Limited | Director | 13 May 2021 | 5 Years 6 Months | Current |
| Aniket Padmakar Manathkar | Director | 13 May 2021 | 5 Years 6 Months | Current |
Auditor
Corerx Pharma India Private Limited is audited by Mahesh C. Solanki & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mahesh C. Solanki & Co | FY 2023 | 006228C |
Shareholding
The shareholding of Corerx Pharma India Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Corerx Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Corerx Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Corerx Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Corerx Pharma India Private Limited has a workforce of 18 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 18 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Corerx Pharma India Private Limited, buy the company report.
GST
Corerx Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCC4795N1ZU | Maharashtra | Active | 14 Jun 2021 |
To see the full GST registrations and return filing status of Corerx Pharma India Private Limited, buy the company report.
Recent activity
Corerx Pharma India Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Aniket Padmakar Manathkar was appointed as Director on 13 May 2021.
News
Frequently asked questions
Corerx Pharma India is an active foreign private limited company based in Bangalore, Karnataka, India. The company works in business support services, within the business services industry. It was incorporated on 13 May 2021 (5+ years old) and is registered under CIN U24304KA2021FTC147384.
Corerx Pharma India has 2 current directors:
- Jayesh Patel - Director
- Aniket Padmakar Manathkar - Director
The latest financial statements of Corerx Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Corerx Pharma India is 27AAJCC4795N1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Corerx Pharma India is U24304KA2021FTC147384. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Corerx Pharma India was incorporated on 13 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Aniket Padmakar Manathkar was appointed as Director on 13 May 2021. Jayesh Patel was appointed as Director on 13 May 2021.
Corerx Pharma India can be reached through the website corerxpharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Corerx Pharma India is at 8754 6th Sector Hsr Layout, Bangalore, Karnataka, India – 560102.
Corerx Pharma India operates in the business services industry, in the business support services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
